- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02593292
Program of Research for the Optimization of a Supervised Patient Pathway for Expectant According to Risk in Obstetrics (PROSPERO)
February 12, 2019 updated by: Hospices Civils de Lyon
This French multicentre open-label randomized trial will test the hypothesis that a coordinated health circuit based on obstetric risks, backed up by an electronic patient care reporting information system will optimize the continuum of pregnancy care monitoring.
The electronic patient care reporting information system will be shared between patients, private practice physicians/midwifes, hospital physicians/midwifes and supervised by a coordinating midwife.
Study Overview
Study Type
Interventional
Enrollment (Actual)
1532
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bron, France, 69677
- Hôpital Femme Mère Enfant
-
Lyon, France, 69002
- Hospices Civils de Lyon
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- patients over the age of majority,
- enrolled in one of the two maternity hospitals in the study before 12 weeks of amenorrhea (SA) and 6 days (j) of age,
- affiliated to the National Health Insurance Fund of the country within the regional level health insurance
- have an internet access
Exclusion Criteria:
- illiterate patients,
- non-French speakers,
- under the age of majority,
- refusing to participate,
- without internet access,
- followed by one of these maternity wards but delivering else where,
- whose pregnancy ended in a miscarriage early or late (before 21 weeks of amenorrhea (SA) and 6 days (J) over).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: control group
|
At the start of the pregnancy, medical, obstetric and social risk factors are checked in the same way than the PROSPERO group.
An adapted patient pathway was defined by a Clinical Research Assistant but unreachable from patients, midwifes and physicians.
The electronic patient care reporting information system will be disabled and midwifes cannot create the classification checklist for low or high risk delivery.
|
Active Comparator: PROSPERO group (intervention group)
|
The intervention is carried out in 3 steps:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of patients'pathway approved as compliant in the intervention group compared to the control group.
Time Frame: at the end of pregnancy
|
Compliant patient pathways are those for which all actions (medical visits, examinations, …) recommended during pregnancy, according to the specific risk factors of each patient, will have been made.
|
at the end of pregnancy
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
rate of severe maternal morbidity and mortality as defined by the EPIdémiologie de la MOrbidité Maternelle Sévère (EPINOMS) project
Time Frame: From 22 completed weeks (154 days) of gestation to seven completed days after birth
|
From 22 completed weeks (154 days) of gestation to seven completed days after birth
|
|
rate of perinatal morbidity-mortality as defined by the Organization, Practices Evaluation in perinatal Network
Time Frame: From 22 completed weeks (154 days) of gestation to seven completed days after birth
|
From 22 completed weeks (154 days) of gestation to seven completed days after birth
|
|
completeness of all hospital medical records
Time Frame: the end of pregnancy (the date of delivery)
|
completeness of hospital medical records compared to electronic patient-reported outcome (ePRO).
|
the end of pregnancy (the date of delivery)
|
health care costs
Time Frame: one week from the date of delivery
|
Number of medical visits and hospitalization
|
one week from the date of delivery
|
health care costs
Time Frame: one week from the date of delivery
|
duration of medical visits and hospitalization
|
one week from the date of delivery
|
patients' satisfaction : Qualitative evaluation by interview
Time Frame: at the end of pregnancy
|
Qualitative evaluation of patients' satisfaction and adherence by interview and/or focus groups.
Quantitative evaluation of patients' satisfaction and anxiety by the hospital anxiety and depression scale and other validated's patient satisfaction forms
|
at the end of pregnancy
|
patients' satisfaction : Quantitative evaluation by the hospital anxiety and depression scale
Time Frame: at the end of pregnancy
|
Quantitative evaluation of patients' satisfaction and anxiety by the hospital anxiety and depression scale
|
at the end of pregnancy
|
patients' satisfaction : Qualitative evaluation by interview
Time Frame: within one week from the date of delivery
|
Qualitative evaluation of patients' satisfaction and adherence by interview and/or focus groups.
|
within one week from the date of delivery
|
patients' satisfaction : Quantitative evaluation by the hospital anxiety and depression scale
Time Frame: within one week from the date of delivery
|
Quantitative evaluation of patients' satisfaction and anxiety by the hospital anxiety and depression scale and other validated's patient satisfaction forms
|
within one week from the date of delivery
|
types of delivery
Time Frame: within one week from the date of delivery
|
rate of vaginal delivery, instrumental extraction delivery, Caesarean delivery
|
within one week from the date of delivery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: René-Charles RUDIGOZ, Pr, Hospices Civils de Lyon
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 5, 2016
Primary Completion (Actual)
July 1, 2018
Study Completion (Actual)
July 1, 2018
Study Registration Dates
First Submitted
October 28, 2015
First Submitted That Met QC Criteria
October 29, 2015
First Posted (Estimate)
November 1, 2015
Study Record Updates
Last Update Posted (Actual)
February 15, 2019
Last Update Submitted That Met QC Criteria
February 12, 2019
Last Verified
February 1, 2019
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 69HCL14_0454
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy
-
Far Eastern Memorial HospitalCompletedCornual PregnancyTaiwan
-
Peking Union Medical College HospitalPeking Union Medical CollegeUnknownPregnancy | Pregnancy Related | Infant | Pregnancy Disease | Risk FactorChina
-
Ufuk UniversityNot yet recruitingPregnancy Complications | Pregnancy Loss | Pregnancy Preterm
-
Hadassah Medical OrganizationCompleted
-
Centre Hospitalier Universitaire de Saint EtienneCompletedProlonged PregnancyFrance
-
University Hospital, ToursCompleted
-
Technische Universität DresdenWithdrawnPregnancy Trimester, Second | Pregnancy Trimester, First | Pregnancy Trimester, ThirdGermany
-
Universitair Ziekenhuis BrusselMerck Serono International SAUnknownPregnancy | Pregnancy LossBelgium
-
Turku University HospitalUniversity of TurkuCompleted
-
Hopital Antoine BeclereUnknown